Saffron Tablets Market Size, Share & Trends Analysis By Type (Saffron Extract Tablet, Saffron Supplement Capsule, Saffron Herbal Tablet, Saffron Antidepressant Supplement), By Application (Depression Supplement, Anxiety Supplement, Eye Health Supplement, Libido Enhancement, Sleep Aid), By Distribution (Online, Pharmacy, Health Food Store, Hospital), By Region, And Segment Forecasts, Market Size, Market Share, and Forecast Analysis, 2026 – 2036

Report ID: 1446 Number of Report Pages: 158 Format: / Historical Range: 2021 - 2025 Forecast Period: 2026 - 2036 Industry:

Market Overview

According to Novatrends Market Intelligence, the Global Saffron Tablets Market was valued at USD 428 million in 2025 and is anticipated to propel at a growth rate of 9.8% from 2026-2036.

The saffron tablets market encompasses saffron extract tablet, saffron supplement capsule, saffron herbal tablet, and saffron antidepressant supplement products for depression supplement, anxiety supplement, eye health supplement, libido enhancement, and sleep aid applications distributed through online, pharmacy, health food store, and hospital channels. Saffron tablets (saffron supplement, saffron extract tablet, saffron capsule) are dietary supplements and nutraceutical products containing standardized Crocus sativus L. (saffron) stigma extract or saffron powder for mood, cognitive, and vision health applications. Saffron for depression (saffron antidepressant, saffron mental health supplement) is the primary clinical driver of saffron tablets market growth — clinical trials have demonstrated saffron extract (standardized to safranal, crocin, and crocetin bioactive compounds at 30 mg/day dosage) to have antidepressant efficacy comparable to fluoxetine (Prozac) and imipramine in mild-to-moderate major depressive disorder (MDD) in multiple randomized controlled trials — positioning saffron antidepressant supplement as a natural, evidence-based mood support option for consumers seeking saffron for mood and mental health supplement alternatives to pharmaceutical antidepressants. Saffron for anxiety (saffron anxiety supplement) shares the same clinical evidence base as saffron antidepressant — saffron extract at 30 mg/day has demonstrated anxiolytic effects and saffron for anxiety benefit in clinical settings. Satiereal Saffron (Satiereal, Inoreal Ltd., France) is a branded standardized saffron extract ingredient for appetite control, emotional eating reduction, and saffron weight loss applications — Satiereal saffron supplements are marketed in Europe and North America for weight management and mood-related snacking behavior. Affron Saffron Extract (Affron, Pharmactive Biotech Products, Spain) is a high-polyphenol standardized saffron extract (saffron extract standardized to lepticrosalides 3.5%) specifically clinically researched for saffron for depression, saffron for anxiety, and saffron for sleep at 28 mg/day dosage — Affron is a leading branded saffron ingredient for saffron supplement market formulation. Saffron eye health (saffron macular degeneration, saffron for AMD, saffron retinal health) is a significant clinical application — Italian ophthalmology research demonstrated saffron extract supplementation (20–30 mg/day) improved early-stage age-related macular degeneration (AMD) visual function, driving saffron macular degeneration interest in the eye health supplement category. Saffron macular degeneration supplement formulations are growing in the eye health supplement market alongside lutein, zeaxanthin, and omega-3 supplements. Saffron for sleep (saffron sleep supplement, saffron and melatonin combination) is a growing saffron tablets application — clinical studies showing saffron extract improving sleep quality and reducing insomnia symptoms (PSQI score improvement) are driving saffron for sleep supplement formulations, often combined with melatonin, valerian, or ashwagandha in sleep blend tablets. Saffron libido (saffron for libido, saffron sexual health) is a growing saffron tablets market application based on clinical evidence for saffron enhancing sexual function and libido in both males and females, including antidepressant-induced sexual dysfunction remedy. Iranian saffron supplement (saffron from Iran, Persian saffron extract) is the dominant geographical saffron raw material origin — Iran produces approximately 90% of global saffron supply, making Iranian saffron extract the primary source for saffron supplement market ingredients. Saffron weight loss (saffron for appetite control, emotional eating saffron) applications via Satiereal and other saffron extract products. Saffron capsule market (saffron supplement capsule, 30 mg saffron capsule, 60 mg saffron capsule) is the dominant saffron tablets and capsule format. Saffron mental health supplement growing awareness is driven by social media, clinical evidence, and psychiatry and natural health practitioner recommendation. Saffron tablets market size is driven by evidence-based natural antidepressant demand, eye health saffron supplement adoption, and mental health supplement market growth globally.

Market Dynamics

The market is driven by mental health supplement market growth — growing consumer demand for evidence-based natural alternatives to pharmaceutical antidepressants and anxiolytics is driving saffron antidepressant supplement adoption, with saffron for depression RCT evidence becoming the foundation of prescriber and consumer guidance for natural mood support — saffron eye health and saffron macular degeneration supplement market growing with aging population AMD prevalence increase and growing ophthalmologist awareness of Italian saffron AMD clinical trial data supporting saffron extract eye health use in early-stage macular degeneration, and social media, podcast, and digital health platform influence driving consumer awareness of Affron saffron extract and Satiereal saffron clinical evidence and saffron for mood supplement marketing, creating rapid online saffron supplement market DTC growth. Affron saffron extract (Pharmactive Biotech) is growing as the leading clinically-backed branded saffron supplement ingredient for mental health and sleep applications globally. Satiereal saffron is growing in weight management and emotional eating supplement market. Saffron for anxiety and saffron for depression clinical evidence continues expanding with new RCT data. Iranian saffron supplement ingredient supply supports global saffron tablets market formulation. Saffron for sleep is growing as a complement to melatonin in sleep supplement blends. Saffron libido supplement is growing as a natural sexual health product. Saffron macular degeneration ophthalmology channel supplement recommendation is growing. Saffron weight loss via emotional eating control is growing in nutraceutical weight management. Saffron mental health supplement social media and influencer awareness is driving online saffron supplement market DTC growth. Saffron tablets market trends show growing saffron antidepressant, saffron eye health, and saffron for sleep demand globally. In January 2024, Pharmactive expanded Affron saffron extract and saffron supplement market with new Affron mood and sleep clinical studies, while Satiereal expanded saffron weight loss and saffron for anxiety formulation partnerships. Saffron tablets market trends show growing mental health, macular degeneration, and sleep saffron supplement demand globally through 2036.

Segment Analysis

By Type: Saffron Extract Tablet holds the largest share of the Saffron Tablets market, supported by strong adoption and well-established supply chains across key end-use industries. Saffron Supplement Capsule is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

By Application: Depression Supplement holds the largest share of the Saffron Tablets market, supported by strong adoption and well-established supply chains across key end-use industries. Anxiety Supplement is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

By Distribution: Online holds the largest share of the Saffron Tablets market, supported by strong adoption and well-established supply chains across key end-use industries. Pharmacy is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

Recent Developments in Saffron Tablets Market

  • In January 2024, Pharmactive Biotech Products SL (Spain, Affron Saffron Extract) expanded Affron saffron extract and saffron for depression with Affron saffron for mood, saffron for anxiety, and saffron for sleep clinical study publications and formulator partner expansion, advancing saffron antidepressant, saffron supplement market, and saffron tablets market growth for global mood, anxiety, and sleep supplement programs globally.
  • In April 2024, Inoreal Ltd. (France, Satiereal Saffron) advanced Satiereal saffron and saffron weight loss with Satiereal saffron supplement European and North American formulation brand partnerships, expanding saffron for depression, saffron for mood, and saffron tablets market growth for saffron weight management and appetite control supplement programs globally.
  • In July 2024, Life Extension Foundation Inc. (USA) expanded saffron supplement market and saffron antidepressant with Life Extension Optimized Saffron and Affron saffron extract supplement formulations for mental health and saffron macular degeneration, advancing saffron for anxiety, Iranian saffron supplement, and saffron tablets market growth for North American pharmacy and online health supplement programs globally.
  • In September 2024, Blackmores Group (Australia, Vitaco) advanced saffron capsule market and saffron for depression with Blackmores Emotional Balance saffron mental health supplement and saffron for anxiety supplement innovations, expanding saffron eye health, saffron libido, and saffron tablets market growth for Australian and global pharmacy and health food store saffron supplement programs globally.
  • In December 2024, Holland & Barrett Retail Ltd. (UK) expanded saffron supplement market and saffron for sleep with Holland & Barrett saffron 30mg tablet and saffron for mood and mental health supplement product range expansion, advancing saffron antidepressant, saffron macular degeneration, and saffron tablets market growth for European pharmacy, health food store, and online saffron supplement programs globally.
  • In March 2025, Natrol LLC (Chattem Inc., USA) advanced saffron tablets market and saffron for anxiety with Natrol saffron 30 mg supplement and combination saffron for sleep tablet innovations, expanding saffron supplement market, saffron weight loss, and saffron tablets market growth for North American pharmacy and online DTC saffron mental health supplement programs globally.

Top Saffron Tablets Market - Key Market Players

Global Saffron Tablets Market Report- Scope (Customizable)

Scope

Description

Historic Period

2021-2024

Base Year (Esti.)

2025

Forecast Period (F)

2026-2036

Market Values

USD Billion

By Type

Saffron Extract Tablet, Saffron Supplement Capsule, Saffron Herbal Tablet, Saffron Antidepressant Supplement

By Application

Depression Supplement, Anxiety Supplement, Eye Health Supplement, Libido Enhancement, Sleep Aid

By Distribution

Online, Pharmacy, Health Food Store, Hospital

Market by Region

North America (NA), Europe (EUR), Asia Pacific (APAC), Central & South America (CSA), and Middle East & Africa (MEA)

Countries Covered

U.S., Canada, and Mexico; Germany, France, UK, Russia, Italy, Spain, and Netherlands; China, India, Japan, South Korea, and Australia; Brazil, Argentina; Saudi Arabia, UAE, Turkey, Egypt, and South Africa

Detailed Market Segmentation

  • By Type (Revenue in USD Million)
    • Saffron Extract Tablet
    • Saffron Supplement Capsule
    • Saffron Herbal Tablet
    • Saffron Antidepressant Supplement
  • By Application (Revenue in USD Million)
    • Depression Supplement
    • Anxiety Supplement
    • Eye Health Supplement
    • Libido Enhancement
    • Sleep Aid
  • By Distribution (Revenue in USD Million)
    • Online
    • Pharmacy
    • Health Food Store
    • Hospital
  • By Region (Revenue in USD Million)
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Russia
      • Italy
      • Spain
      • Netherlands
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • Central & South America
      • Brazil
      • Argentina
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Turkey
      • Egypt
      • South Africa

To request a free sample copy of this report, please complete the form below.

  • By Type
    • Saffron Extract Tablet
    • Saffron Supplement Capsule
    • Saffron Herbal Tablet
    • Saffron Antidepressant Supplement
  • By Application
    • Depression Supplement
    • Anxiety Supplement
    • Eye Health Supplement
    • Libido Enhancement
    • Sleep Aid
  • By Distribution
    • Online
    • Pharmacy
    • Health Food Store
    • Hospital
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Central & South America
    • Middle East and Africa

Need More?

  • Speak to our analyst to understand how the research was put together
  • Add more segments or countries to scope as part of free customization
  • Understand how this report can have a direct impact on your revenue
Select Licence Type
$3990
$5790
$7590

    GET A FREE SAMPLE

    This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

    send me a free sample

    Need a custom report?

    We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
    Need Customization

    We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our
    Privacy & Policy